# A Study of Antipsychotics in Individuals at Clinical High-risk for Psychosis (the SHARP-2 Study)

> **NCT04010864** · — · UNKNOWN · sponsor: **Shanghai Mental Health Center** · enrollment: 600 (estimated)

## Conditions studied

- Clinical High-risk

## Interventions

- **OTHER:** routine clinical treatment

## Key facts

- **NCT ID:** NCT04010864
- **Lead sponsor:** Shanghai Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-29
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2020-10-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04010864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04010864, "A Study of Antipsychotics in Individuals at Clinical High-risk for Psychosis (the SHARP-2 Study)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04010864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*